JUNSHI BIO Revamps Board Committee to Include ESG Oversight

Stock News
03/13

JUNSHI BIO (01877) has announced that its board of directors has passed a resolution to reconfigure the existing Strategy Committee into a Strategy and ESG Committee, effective March 13, 2026. This adjustment is intended to enhance the company's management of environmental, social, and governance (ESG) standards and bolster its sustainable development capabilities. The change is made in accordance with relevant legal provisions and the company's articles of association, taking into account its current operational context. The corresponding internal guidelines have also been updated from the "Strategy Committee Working Rules" to the "Strategy and ESG Committee Working Rules," expanding the committee's responsibilities to include ESG management alongside its existing functions. The Strategy and ESG Committee will primarily focus on studying the company's long-term development strategy, major investment decisions, sustainability, and ESG matters, providing recommendations to the board. This update only affects the committee's name and duties; its membership composition and term regulations remain unchanged.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10